HPS1785-95
220810-26-4
默认>95%HPLC，若需其他规格请洽询
| 产品编号 | 规格 | 货期 | 销售价 | 折扣价 | 数量 | 操作 |
|---|---|---|---|---|---|---|
| HPS1785-95 | 默认>95%HPLC，若需其他规格请洽询 |
25天
|
敬请询价 | 敬请询价 |
 
|
| 名字 | (Des-Gly¹⁰,D-His(Bzl)⁶,Pro-NHEt⁹)-LHRH acetate salt |
|---|---|
| 序列(三字母) | Pyr-His-Trp-Ser-Tyr-D-His(Bzl)-Leu-Arg-Pro-NHEt acetate salt |
| 序列(单字母) | Pyr-HWSYh(Bzl)LRP-NHEt |
| CAS# | 220810-26-4 |
| 分子式 | C₆₆H₈₆N₁₈O₁₂ |
| 分子量 | 1323.52 |
| 纯度 | 默认>95%HPLC，若需其他规格请洽询 |
| 合成方法 | Synthetic |
| 储存条件 | -20 ± 5 °C |
| 应用 | Cancer Research|Pituitary & Hypothalamic Hormones |
| 描述 | As a potent LHRH agonist, histrelin stimulates LH and FSH release and inhibits the actions of sex steroids on the male and female reproductive tracts. Its potency in vivo and in vitro is similar to that of the D-Trp⁶-containing analog. Especially because of its high water solubility and greater lipophilic character, histrelin appears promising for clinical application.Slow-release implants containing histreline implants were approved for the palliative treatment of advanced hormone-dependent prostate cancer. CAS Number (histrelin acetate): 76712-82-8. |
